Thuy V Tran
Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )
Most Active Art Unit | 2821 |
Art Unit(s) | 2821, 2844, 2856, 2814 |
Total Applications | 2202 |
Issued Applications | 1909 |
Pending Applications | 47 |
Abandoned Applications | 246 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18764231
[patent_doc_number] => 11814618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Methods for co-isolation of nucleic acids and proteins
[patent_app_type] => utility
[patent_app_number] => 17/559456
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 14087
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559456
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559456 | Methods for co-isolation of nucleic acids and proteins | Dec 21, 2021 | Issued |
Array
(
[id] => 17733255
[patent_doc_number] => 20220218714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHOD OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/557649
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557649
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557649 | METHOD OF TREATING CANCER | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17532293
[patent_doc_number] => 20220110902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Methods of treating amyloid-beta peptide diseases
[patent_app_type] => utility
[patent_app_number] => 17/554927
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554927 | Methods of treating amyloid-beta peptide diseases | Dec 16, 2021 | Pending |
Array
(
[id] => 18435979
[patent_doc_number] => 20230183273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/551252
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551252 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | Dec 14, 2021 | Pending |
Array
(
[id] => 17519209
[patent_doc_number] => 20220105057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/551922
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551922 | Methods of treatment | Dec 14, 2021 | Issued |
Array
(
[id] => 19373885
[patent_doc_number] => 12065434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Metabolites of GLP1R agonists
[patent_app_type] => utility
[patent_app_number] => 17/546207
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 30353
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546207 | Metabolites of GLP1R agonists | Dec 8, 2021 | Issued |
Array
(
[id] => 18550702
[patent_doc_number] => 20230248702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => MICELLE COMPRISING BENZIMIDAZOLE-CARBOHYDRATE CONJUGATE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF AS ANTICANCER AGENT OR ANTIVIRAL AGENT COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/544514
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544514 | Micelle comprising benzimidazole-carbohydrate conjugate compound, preparation method thereof and use thereof as anticancer agent or antiviral agent comprising the same | Dec 6, 2021 | Issued |
Array
(
[id] => 18748428
[patent_doc_number] => 11807726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Method of crosslinking glycosaminoglycans
[patent_app_type] => utility
[patent_app_number] => 17/535314
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12052
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/535314 | Method of crosslinking glycosaminoglycans | Nov 23, 2021 | Issued |
Array
(
[id] => 17593616
[patent_doc_number] => 20220143189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/533559
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533559 | Carbohydrate conjugates as delivery agents for oligonucleotides | Nov 22, 2021 | Issued |
Array
(
[id] => 17609811
[patent_doc_number] => 20220152090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHOD FOR TREATING AMYLOIDOGENIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/454748
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454748
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/454748 | METHOD FOR TREATING AMYLOIDOGENIC DISEASE | Nov 11, 2021 | Pending |
Array
(
[id] => 18361226
[patent_doc_number] => 20230142817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Increased isoelectric points for preventive compounds for covid 19 treatments
[patent_app_type] => utility
[patent_app_number] => 17/300780
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300780 | Increased isoelectric points for preventive compounds for covid 19 treatments | Nov 4, 2021 | Abandoned |
Array
(
[id] => 17428301
[patent_doc_number] => 20220056009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/519486
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17519486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/519486 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | Nov 3, 2021 | Issued |
Array
(
[id] => 17576905
[patent_doc_number] => 20220133760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => IDENTIFICATION AND TREATMENT OF T-CELL EPITOPES OF SHORT H2A ONCOHISTONES
[patent_app_type] => utility
[patent_app_number] => 17/516600
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17516600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/516600 | Identification and treatment of T-cell epitopes of short H2A oncohistones | Oct 31, 2021 | Issued |
Array
(
[id] => 17655356
[patent_doc_number] => 20220175821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHODS FOR IMPROVING ANTI-OXIDATION AND PREVENTING/TREATING DISEASES USING HYPO-ACYLATED LIPOPOLYSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 17/511888
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511888
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511888 | METHODS FOR IMPROVING ANTI-OXIDATION AND PREVENTING/TREATING DISEASES USING HYPO-ACYLATED LIPOPOLYSACCHARIDE | Oct 26, 2021 | Abandoned |
Array
(
[id] => 17609928
[patent_doc_number] => 20220152207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Polymeric Paste Compositions for Drug Delivery
[patent_app_type] => utility
[patent_app_number] => 17/497766
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497766 | Polymeric Paste Compositions for Drug Delivery | Oct 7, 2021 | Pending |
Array
(
[id] => 19011662
[patent_doc_number] => 11918562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Combination therapy using azabicyclo compound for cancer
[patent_app_type] => utility
[patent_app_number] => 17/490256
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18019
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/490256 | Combination therapy using azabicyclo compound for cancer | Sep 29, 2021 | Issued |
Array
(
[id] => 17546649
[patent_doc_number] => 20220117990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => KRAS ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/449275
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17449275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/449275 | KRAS ANTAGONISTS | Sep 28, 2021 | Pending |
Array
(
[id] => 17392410
[patent_doc_number] => 11241398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Affinity medicant conjugate
[patent_app_type] => utility
[patent_app_number] => 17/482242
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 73
[patent_no_of_words] => 49563
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482242 | Affinity medicant conjugate | Sep 21, 2021 | Issued |
Array
(
[id] => 17520565
[patent_doc_number] => 20220106414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => NATURAL HYDROCOLLOID SYSTEMS FOR PET FOOD COMPOSITIONS, PET FOOD COMPOSITIONS COMPRISING SAME, AND PREPARATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/479082
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479082 | Natural hydrocolloid systems for pet food compositions, pet food compositions comprising same, and preparations thereof | Sep 19, 2021 | Issued |
Array
(
[id] => 18518440
[patent_doc_number] => 11708318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Polymorphic forms of RAD1901-2HCL
[patent_app_type] => utility
[patent_app_number] => 17/475018
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 63
[patent_no_of_words] => 16578
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/475018 | Polymorphic forms of RAD1901-2HCL | Sep 13, 2021 | Issued |